cell and gene therapy

cell and gene therapy

China’s CGT Surge: Unpacking A Nature Review on Regulatory Reform, Pipeline Trends & Global Implications

China’s cell and gene therapy (CGT) ecosystem is rapidly evolving with fast-track IND/NDA pathways, expanding pipelines, and global relevance. This analysis breaks down the key takeaways from a major Nature Reviews article and explores what they mean for developers, investors, and regulators.